Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucas G Hill

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|January 8, 2014
Lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapyLucas G Hill
American Journal of Pharmaceutical Education|February 1, 2020
Guidance for Male Mentors to Support the Safety and Success of Female MenteesLucas G Hill, S Andrea Laguado
JAMA Internal Medicine|October 8, 2019
State-Level Approaches to Expanding Pharmacists' Authority to Dispense Naloxone May Affect AccessibilityLucas G Hill, Kelly R Reveles, Kirk E Evoy
Integrated Pharmacy Research & Practice|February 24, 2021
Considering the Potential Benefits of Over-the-Counter NaloxoneKirk E Evoy, Lucas G Hill, Corey S Davis
Integrated Pharmacy Research & Practice|July 16, 2021
Reply to Letter to the Editor Regarding Article: "Considering the Potential Benefits of Over-The-Counter Naloxone" [Response To Letter]Kirk E Evoy, Lucas G Hill, Corey S Davis
Journal of the American Pharmacists Association : Japha|August 13, 2019
Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reductionLucas G Hill, Kirk E Evoy, Kelly R Reveles
The International Journal on Drug Policy|September 25, 2020
Isotonitazene as a contaminant of concern in the illegal opioid supply: A practical synthesis and cost perspectiveClaire M Zagorski, James M Myslinski, Lucas G Hill
Journal of the American Pharmacists Association : Japha|March 31, 2020
ReplyLucas G Hill, Kirk E Evoy, Kelly R Reveles
The Mental Health Clinician|July 14, 2023
Medications for opioid use disorder in professional recovery programs in the United States: Policies and recommendation patternsMorgan L Murchison, Lindsey J Loera, Lucas G Hill
Journal of the American Pharmacists Association : Japha|July 20, 2025
Encouraging OTC Naloxone Accessibility Across the United StatesDeclan M Folan, Lucas G Hill, Lucas A Berenbrok
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|January 8, 2014
Lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapyLucas G Hill
American Journal of Pharmaceutical Education|February 1, 2020
Guidance for Male Mentors to Support the Safety and Success of Female MenteesLucas G Hill, S Andrea Laguado
JAMA Internal Medicine|October 8, 2019
State-Level Approaches to Expanding Pharmacists' Authority to Dispense Naloxone May Affect AccessibilityLucas G Hill, Kelly R Reveles, Kirk E Evoy
Integrated Pharmacy Research & Practice|February 24, 2021
Considering the Potential Benefits of Over-the-Counter NaloxoneKirk E Evoy, Lucas G Hill, Corey S Davis
Integrated Pharmacy Research & Practice|July 16, 2021
Reply to Letter to the Editor Regarding Article: "Considering the Potential Benefits of Over-The-Counter Naloxone" [Response To Letter]Kirk E Evoy, Lucas G Hill, Corey S Davis
Journal of the American Pharmacists Association : Japha|August 13, 2019
Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reductionLucas G Hill, Kirk E Evoy, Kelly R Reveles
The International Journal on Drug Policy|September 25, 2020
Isotonitazene as a contaminant of concern in the illegal opioid supply: A practical synthesis and cost perspectiveClaire M Zagorski, James M Myslinski, Lucas G Hill
Journal of the American Pharmacists Association : Japha|March 31, 2020
ReplyLucas G Hill, Kirk E Evoy, Kelly R Reveles
The Mental Health Clinician|July 14, 2023
Medications for opioid use disorder in professional recovery programs in the United States: Policies and recommendation patternsMorgan L Murchison, Lindsey J Loera, Lucas G Hill
Journal of the American Pharmacists Association : Japha|July 20, 2025
Encouraging OTC Naloxone Accessibility Across the United StatesDeclan M Folan, Lucas G Hill, Lucas A Berenbrok
Pageof 5